Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 34Busulfan 17Cyclophosphamide 16fludarabine phosphate 15Peripheral Blood Stem Cell Transplantation 13Filgrastim 13Etoposide 13Idarubicin 12Mitoxantrone 9Cyclosporine 9Antilymphocyte Serum 9Methotrexate 8Daunorubicin 8Whole-Body Irradiation 6Radiotherapy 6Tacrolimus 5Cord Blood Stem Cell Transplantation 5Clofarabine 5Mycophenolic Acid 4Methylprednisolone 4Melphalan 4Gemtuzumab 4Flow Cytometry 4Arsenic Trioxide 4aldesleukin 3Topotecan 3Imatinib Mesylate 3Cytogenetic Analysis 3Cyclosporins 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Erythroblastic, Acute × Podophyllotoxin × Clear all
NCT01127009 2015-08-13

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

Case Comprehensive Cancer Center

Phase 1 Completed
3 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡